We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Lab-on-Chip Identifies and Differentiates Tropical Pathogens

By LabMedica International staff writers
Posted on 13 Aug 2014
Print article
Image: A lab-on-chip to identify and differentiate tropical pathogens (Photo courtesy of the Agency for Science, Technology and Research).
Image: A lab-on-chip to identify and differentiate tropical pathogens (Photo courtesy of the Agency for Science, Technology and Research).
Tropical pathogens often cause febrile illnesses in humans and are responsible for considerable morbidity and mortality and the similarities in clinical symptoms provoked by these pathogens make diagnosis difficult.

A microfluidic lab-on-chip integrating multiplex molecular amplification and DNA microarray hybridization has been developed for simultaneous detection and species differentiation of 26 globally important tropical pathogens.

A multinational team of scientists working with the Agency for Science, Technology and Research (A*STAR; Biopolis, Singapore) collected plasma samples from 30 polymerase chain reaction (PCR)-confirmed Chikungunya virus (CHIKV) patients, 125 archived nuclei acid samples extracted from specimens from a malaria clinic, and non-malaria specimens collected from patients presenting with undifferentiated febrile illness were also evaluated with the lab-on-chip.

The microfluidic technology was combined with reverse transcription (RT), PCR amplification, and microarray hybridization to develop silicon based micro-electromechanical systems (MEMS) integrated lab-on-chip that can simultaneously detect and differentiate between 26 pathogen species, including bacteria, parasites and viruses, that cause 14 tropical diseases. The lab-on-chip was scanned in an optical reader (Veredus Laboratories; Singapore) which has an excitation filter for Cyanine 5 (Cy5).

The analytical performance of the lab-on-chip for each pathogen ranged from 102 to 103 DNA or RNA copies. Assay performance was further verified with human whole blood spiked with Plasmodium falciparum and Chikungunya virus that yielded a range of detection from 200 to 4×105 parasites and from 250 to 4×107 plaque-forming units (PFU) respectively. This lab-on-chip was subsequently assessed and evaluated using 170 retrospective patient specimens in Singapore and Thailand.

The lab-on-chip had a detection sensitivity of 83.1% and a specificity of 100% for P. falciparum; a sensitivity of 91.3% and a specificity of 99.3% for P. vivax; a positive 90.0% agreement and a specificity of 100% for Chikungunya virus; and a positive 85.0% agreement and a specificity of 100% for Dengue virus serotype 3 with reference methods conducted on the samples.

The authors concluded that the lab-on-chip assay showed that miniaturized multiplex PCR could reach the desired clinical sensitivity; future work should attempt to recalibrate the mix of multiplex primers and modify amplification cycling conditions for improved sensitivity. One of the key milestones for lab-on-chip systems would be the direct testing of clinical specimens obtained during the acute infection phase and provide accurate diagnosis to complement clinical assessments. The study was published on July 31, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Agency for Science, Technology and Research
Veredus Laboratories



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.